AMN Healthcare Services (AMN) 10-Q 1 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Jul. 30, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'AMN HEALTHCARE SERVICES INC	'
Entity Central Index Key	'0001142750	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	46,501,082

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$5,501	$15,580
Accounts receivable, net of allowances of $5,076 and $5,118 at June 30, 2014 and December 31, 2013, respectively	151,505	147,477
Accounts receivable, subcontractor	22,512	18,271
Deferred income taxes, net	27,983	24,938
Prepaid and other current assets	27,662	26,631
Total current assets	235,163	232,897
Restricted cash, cash equivalents and investments	20,606	23,115
Fixed assets, net of accumulated depreciation of $66,809 and $63,031 at June 30, 2014 and December 31, 2013, respectively	27,066	21,158
Other assets	37,502	32,279
Goodwill	144,937	144,642
Intangible assets, net of accumulated amortization of $38,102 and $42,439 at June 30, 2014 and December 31, 2013, respectively	146,418	150,197
Total assets	611,692	604,288
Current liabilities:	'	'
Accounts payable and accrued expenses	65,130	71,081
Accrued compensation and benefits	56,046	55,949
Revolving credit facility	6,500	10,000
Current portion of notes payable	7,500	0
Other current liabilities	4,097	6,060
Total current liabilities	139,273	143,090
Notes payable, net of discount	140,625	148,672
Other long-term liabilities	98,188	94,784
Total liabilities	378,086	386,546
Commitments and contingencies (Note 9)	'	'
Stockholders’ equity:	'	'
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at June 30, 2014 and December 31, 2013	0	0
Common stock, $0.01 par value; 200,000 shares authorized; 46,501 and 46,011 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively	465	460
Additional paid-in capital	430,137	429,055
Accumulated deficit	-196,452	-211,275
Accumulated other comprehensive loss	-544	-498
Total stockholders’ equity	233,606	217,742
Total liabilities and stockholders’ equity	$611,692	$604,288

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Accounts receivable, allowance	$5,076	$5,118
Accumulated depreciation	66,809	63,031
Accumulated amortization	$38,102	$42,439
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	46,501	46,011
Common stock, shares outstanding	46,501	46,011

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue	$250,913	$253,943	$491,794	$506,063
Cost of revenue	173,754	179,530	340,679	358,643
Gross profit	77,159	74,413	151,115	147,420
Operating expenses:	'	'	'	'
Selling, general and administrative	55,567	54,551	110,234	108,158
Depreciation and amortization	4,010	3,240	7,830	6,530
Total operating expenses	59,577	57,791	118,064	114,688
Income from operations	17,582	16,622	33,051	32,732
Interest expense, net (including loss on debt extinguishment of $3,113 and $434 for both the three and six months ended June 30, 2014 and 2013, respectively) and other	4,629	3,130	6,475	5,989
Income before income taxes	12,953	13,492	26,576	26,743
Income tax expense	5,760	5,093	11,753	10,781
Net Income	7,193	8,399	14,823	15,962
Other comprehensive (loss) income - foreign currency translation	-37	-28	-46	65
Comprehensive income	$7,156	$8,371	$14,777	$16,027
Net income per common share:	'	'	'	'
Basic (in dollars per share)	$0.15	$0.18	$0.32	$0.35
Diluted (in dollars per share)	$0.15	$0.18	$0.31	$0.33
Weighted average common shares outstanding:	'	'	'	'
Basic (shares)	46,479	46,039	46,416	45,927
Diluted (shares)	47,836	47,837	47,876	47,759

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Loss on debt extinguishment	$3,113	$434	$3,113	$434

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net income	$14,823	$15,962
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	7,830	6,530
Non-cash interest expense and other	676	676
Increase in allowances for doubtful accounts and sales credits	2,153	1,648
Provision for deferred income taxes	-1,074	862
Share-based compensation	3,570	3,180
Excess tax benefits from share-based compensation	-1,716	-1,431
Holdback settlement in equity from prior acquisition	0	-3,046
Loss on disposal or sale of fixed assets	4	8
Loss on debt extinguishment	3,113	434
Changes in assets and liabilities:	'	'
Accounts receivable, net	-6,181	-8,936
Accounts receivable, subcontractor	-4,241	2,739
Prepaid expenses and other current assets	-1,002	3,461
Other assets	-54	-2,321
Accounts payable and accrued expenses	-6,037	327
Accrued compensation and benefits	96	-2,572
Other liabilities	1,147	1,886
Restricted cash, cash equivalents and investments balance	-5,957	-2,150
Net cash provided by operating activities	7,150	17,257
Cash flows from investing activities:	'	'
Purchase and development of fixed assets	-9,876	-5,348
Equity method investment	-3,000	0
Payments to fund deferred compensation plan	-1,399	-735
Change in restricted cash, cash equivalents and investments balance	8,466	51
Net cash used in investing activities	-5,809	-6,032
Cash flows from financing activities:	'	'
Capital lease repayments	-313	-318
Repayments on prior term loan	-149,620	0
Payments on current term loan	-1,875	-5,000
Proceeds from current term loan	150,000	0
Proceeds from prior revolving credit facility	10,000	1,000
Repayments on prior revolving credit facility	-20,000	-1,000
Proceeds from current revolving credit facility	19,500	0
Payments on current revolving credit facility	-13,000	0
Payment of financing costs	-3,488	-935
Proceeds from exercise of equity awards	58	767
Cash paid for shares withheld for taxes	-4,243	-2,537
Excess tax benefits from share-based compensation	1,716	1,431
Change in bank overdraft	-109	140
Net cash used in financing activities	-11,374	-6,452
Effect of exchange rate changes on cash	-46	65
Net (decrease) increase in cash and cash equivalents	-10,079	4,838
Cash and cash equivalents at beginning of period	15,580	5,681
Cash and cash equivalents at end of period	5,501	10,519
Supplemental disclosures of cash flow information:	'	'
Cash paid for interest (net of $46 and $43 capitalized for the six months ended June 30, 2014 and 2013, respectively)	2,760	4,233
Cash paid for income taxes	$9,170	$9,345

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Interest capitalized	$46	$43

Basis_of_Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BASIS OF PRESENTATION	'
	BASIS OF PRESENTATION
	The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.
	The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2013, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the Securities and Exchange Commission (“SEC”) on February 21, 2014.
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
	Reclassification
	Certain reclassifications have been made to the prior year’s consolidated financial statements to conform to the current year presentation. Specifically, payments made into the Company’s life insurance policies to assist in funding the deferred compensation plan were reclassified from cash flows from operations to cash flows from investing activities in the unaudited condensed consolidated statement of cash flows for the six months ended June 30, 2013. In addition, the Company reclassified expected insurance recoveries under its professional liability and workers’ compensation policies in the condensed consolidated balance sheet for the year ended December 31, 2013 to conform to the current year presentation. Professional liability and workers’ compensation liability were previously presented net of insurance recoveries. Commencing June 30, 2014, expected insurance recoveries are presented on a gross basis, with the short-term insurance receivable portion included within “Prepaid and other current assets” and the long-term portion included within “Other assets” on the condensed consolidated balance sheet.

Business_Combination_and_Equit

Business Combination and Equity Investment	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
BUSINESS COMBINATION AND EQUITY INVESTMENT	'
	ShiftWise Acquisition
	On November 20, 2013, the Company completed its acquisition of ShiftWise, a leading national provider of web-based healthcare workforce solutions, including its vendor management systems, or “VMS,” utilized by hospitals and other healthcare systems. The strategic combination has added a new and more robust technology platform to the Company’s current workforce solutions offerings and will allow the Company to enhance its managed services business and provide a vendor neutral VMS option for interested clients. The acquisition is not considered a material business combination and, accordingly, pro forma information is not provided. The Company accounted for the acquisition using the acquisition method of accounting and recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The purchase price of the acquisition totaled $39,500, of which $6,000 was deposited in escrow to satisfy any indemnification claims by the Company with respect to, among other customary items, breaches of representations, warranties and covenants by ShiftWise and post-closing purchase price adjustments. The $6,000 deposited in escrow will be disbursed to the selling shareholders in three years following the closing date at $2,000 per annum minus any indemnification claims. As of the date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price. The provisional items pending finalization are primarily related to tax matters, which the Company expects to complete during 2014.
	The preliminary allocation of the purchase price consisted of $9,899 of fair value of assets acquired, $11,801 of liabilities assumed (including $2,933 of deferred tax liabilities), $21,612 of goodwill and $19,790 of identified intangible assets. The intangible assets include the fair value of trade names and trademarks, customer relationships, non-compete agreements and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 8 years. There was no goodwill recognized as part of this acquisition that is deductible for tax purposes.
	The results of operations of ShiftWise have been included in the nurse and allied healthcare staffing segment in the Company’s condensed consolidated financial statements since the date of acquisition.
	Pipeline Equity Investment
	In March 2014, the Company entered into an agreement (the “Pipeline Agreement”) under which it made an initial $2,000 investment in Pipeline Health Holdings LLC (“Pipeline”), a telepharmacy provider. The Company’s ownership percentage in Pipeline at March 31, 2014 was approximately 9%. Under the Pipeline Agreement, the Company committed to invest up to an additional $3,000 contingent upon Pipeline reaching two milestone commitments within a year. In April 2014, the Company made the first milestone investment of $1,000, which together with the initial investment currently represents an ownership percentage in Pipeline of approximately 12%. The investment is accounted for under the equity method of accounting. The Company’s share of Pipeline’s results is included within “Interest expense, net and other” in the accompanying unaudited condensed consolidated statement of comprehensive income for the six months ended June 30, 2014.

Revenue_Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2014
Revenue Recognition [Abstract]	'
REVENUE RECOGNITION	'
	REVENUE RECOGNITION
	Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians and physicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. Payables to subcontractors of $24,936 and $22,051, respectively, were included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet as of June 30, 2014 and the audited consolidated balance sheet as of December 31, 2013.

Net_Income_Per_Common_Share

Net Income Per Common Share	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
NET INCOME PER COMMON SHARE	'
	NET INCOME PER COMMON SHARE
	Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.
	Share-based awards to purchase 385 and 334 shares of common stock for the three months ended June 30, 2014 and 2013, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive. Share-based awards to purchase 373 and 321 shares of common stock for the six months ended June 30, 2014 and 2013, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive.
	The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2014 and 2013, respectively:
		Three Months Ended June 30,				Six Months Ended June 30,
		2014		2013		2014		2013
	Net income	$	7,193	$	8,399	$	14,823	$	15,962
	Net income per common share - basic	$	0.15	$	0.18	$	0.32	$	0.35
	Net income per common share - diluted	$	0.15	$	0.18	$	0.31	$	0.33
	Weighted average common shares outstanding - basic	46,479		46,039		46,416		45,927
	Plus dilutive effect of potential common shares	1,357		1,798		1,460		1,832
	Weighted average common shares outstanding - diluted	47,836		47,837		47,876		47,759

Segment_Information

Segment Information	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
SEGMENT INFORMATION	'
	SEGMENT INFORMATION
	The Company has three reportable segments: nurse and allied healthcare staffing, locum tenens staffing and physician permanent placement services.
	The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
	The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:
		Three Months Ended June 30,				Six Months Ended June 30,
		2014		2013		2014		2013
	Revenue
	Nurse and allied healthcare staffing	$	165,894	$	170,138	$	329,344	$	346,903
	Locum tenens staffing	74,309		72,708		141,180		138,164
	Physician permanent placement services	10,710		11,097		21,270		20,996
		$	250,913	$	253,943	$	491,794	$	506,063
	Segment Operating Income
	Nurse and allied healthcare staffing	$	22,032	$	20,128	$	42,004	$	42,602
	Locum tenens staffing	7,818		4,908		14,691		9,800
	Physician permanent placement services	2,187		2,289		4,318		4,530
		32,037		27,325		61,013		56,932
	Unallocated corporate overhead	8,694		5,985		16,562		14,490
	Depreciation and amortization	4,010		3,240		7,830		6,530
	Share-based compensation	1,751		1,478		3,570		3,180
	Interest expense, net (including loss on debt extinguishment of $3,113 and $434 for both the three and six months ended June 30, 2014 and 2013, respectively) and other	4,629		3,130		6,475		5,989
	Income before income taxes	$	12,953	$	13,492	$	26,576	$	26,743

Fair_Value_Measurement

Fair Value Measurement	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENT	'
	FAIR VALUE MEASUREMENTS
	Fair value represents the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which the Company would conduct a transaction, in addition to the assumptions that market participants would use when pricing the related assets or liabilities, including non-performance risk.
	A three-level hierarchy prioritizes the inputs to valuation techniques used to measure fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of the fair value hierarchy are as follows:
	Level 1—Quoted prices in active markets for identical assets or liabilities.
	Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	Assets Measured on a Recurring Basis
	The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments and the Company’s investments associated with its deferred compensation plan. The following tables present information about these assets and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:
		Fair Value Measurements as of June 30, 2014
		Total		Quoted Prices in
				Active Markets
				for Identical
				Assets
				(Level 1)
	U.S. Treasury securities	$	9,350	$	9,350
	Money market funds	439		439
	Total financial assets measured at fair value	$	9,789	$	9,789
		Fair Value Measurements as of December 31, 2013
		Total		Quoted Prices in
				Active Markets
				for Identical
				Assets
				(Level 1)
	U.S. Treasury securities	$	17,817	$	17,817
	Money market funds	359		359
	Total financial assets measured at fair value	$	18,176	$	18,176
	The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds, and the Company’s investments associated with its deferred compensation plan typically consist of money market funds, which fair values are based on quoted prices in active markets for identical assets.
	Assets Measured on a Non-Recurring Basis
	The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment. If impaired, the carrying values of such assets would be written down to fair value using Level 3 inputs. There were no triggering events identified and no indication of impairment of the Company’s goodwill, indefinite-lived intangible assets, long-lived assets or equity method investment during the six months ended June 30, 2014 and 2013.
	Fair Value of Financial Instruments
	The carrying amount of notes payable approximates its fair value as the instrument’s interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity (significant other observable inputs - level 2). The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

Income_Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of June 30, 2014, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2005. During 2013, the Internal Revenue Service (“IRS”) completed its tax audit of the Company for the years 2007, 2008, 2009 and 2010. The IRS issued a Revenue Agent Report (“RAR”) to the Company related to its completed tax examination. The RAR seeks adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards for 2005-2006. The adjustments to the Company’s taxable income relate to the proposed disallowance of certain per diems paid to our clinicians and locum tenens providers on the Company’s income tax return. Concurrent with the RAR, the Company received an Employment Tax Examination Report (“ETER”) for 2009 and 2010. The ETER adjustments propose additional Company payroll tax liabilities and penalties related to the treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER are mutually exclusive. The RAR and ETER contain multiple tax positions, some of which are contrary to each other.
	The Company has filed a Protest Letter for both the RAR and ETER and intends to defend its position. The Company has held two meetings with the IRS Appeals office and will continue to meet with the IRS Appeals office throughout the course of the year. The Company cannot predict with certainty the timing of a resolution. The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate. Notwithstanding, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.
	The IRS commenced income and payroll tax audits for the years 2011 and 2012 during November 2013.

Notes_Payable_and_Related_Cred

Notes Payable and Related Credit Agreement	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
NOTES PAYABLE AND RELATED CREDIT AGREEMENT	'
	On April 18, 2014, the Company entered into a Credit Agreement (the “Credit Agreement”) with several lenders to provide for two credit facilities (the “New Credit Facilities”) to replace its prior credit facilities, including (A) a $225,000 secured revolving credit facility (the “Revolver”) that includes a $40,000 sublimit for the issuance of letters of credit and a $20,000 sublimit for swingline loans and (B) a $150,000 secured term loan credit facility (the “Term Loan”). In addition, the Credit Agreement provides that the Company may from time to time obtain an increase in the Revolver or the Term Loan or both in an aggregate principal amount not to exceed $125,000 subject to, among other conditions, the arrangement of additional commitments with financial institutions reasonably acceptable to the Company and the administrative agent. The obligations of the Company under the Credit Agreement and the New Credit Facilities are secured by substantially all of the assets of the Company.
	The New Credit Facilities are available for working capital, capital expenditures, permitted acquisitions and general corporate purposes of the Company. The maturity date of the New Credit Facilities is April 18, 2019. At June 30, 2014, the outstanding balance of the Term Loan was $148,125, of which $7,500 is due in the next 12 months, and the outstanding balance under the Revolver was $6,500. At June 30, 2014, with $8,815 of outstanding letters of credit collaterialized by the Revolver, there was $209,685 of available credit under the Revolver.
	Annual principal maturities of the outstanding Term Loan are as follows:
	Six months ending December 31, 2014	$	3,750
	Year ending December 31, 2015	7,500
	Year ending December 31, 2016	7,500
	Year ending December 31, 2017	7,500
	Year ending December 31, 2018	7,500
	Thereafter	$	114,375
		$	148,125
	The Revolver carries an unused fee of 0.25% to 0.35% per annum and each standby letter of credit issued under the Revolver is subject to a letter of credit fee ranging from1.50% to 2.25% per annum of the average daily maximum amount available to be drawn under the standby letter of credit, in each case, depending on the Company’s consolidated leverage ratio, as calculated quarterly in accordance with the Credit Agreement. The Term Loan is subject to amortization of principal of 5.00% per year of the original Term Loan amount, which is $7,500 per annum, and payable in equal quarterly installments. Borrowings under the Term Loan and Revolver bear interest at floating rates, at the Company’s option, based upon either LIBOR plus a spread of 1.50% to 2.25% or a base rate plus a spread of 0.50% to 1.25% (weighted average interest rate of one-month LIBOR plus 1.75% at June 30, 2014). The applicable spread is determined quarterly based upon the Company’s consolidated leverage ratio, as calculated quarterly in accordance with the Credit Agreement.
	The Company used the proceeds from the New Credit Facilities to repay in full all outstanding indebtedness under its prior credit facilities and to pay related transaction costs. In addition, approximately $9,500 of standby letters of credit issued under the prior credit facilities were rolled into and deemed issued under the Revolver.
	In connection with obtaining the New Credit Facilities, the Company incurred $3,488 in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the New Credit Facilities. In addition, the Company wrote off $3,113 of unamortized financing fees and original issue discount, which was recorded as loss on debt extinguishment in the accompanying unaudited condensed consolidated statements of comprehensive income for the three and six months ended June 30, 2014.
	The Credit Agreement contains various customary affirmative and negative covenants, including restrictions on assumption of additional indebtedness, declaration and payment of dividends, dispositions of assets, consolidation into another entity and allowable investments. It also contains financial covenants that require the Company (1) not to exceed a certain maximum consolidated leverage ratio, as calculated in accordance with the Credit Agreement, which is initially set at 4.00 to 1.00 but ultimately steps down to 3.50 to 1.00 beginning with the fiscal quarter ending June 30, 2016, and (2) to maintain a minimum consolidated interest coverage ratio of 2.50 to 1.00, as calculated in accordance with the Credit Agreement.
	Letters of Credit
	At June 30, 2014, the Company maintained outstanding standby letters of credit totaling $18,536 as collateral in relation to its professional liability insurance agreements, workers’ compensation insurance agreements, and a corporate office lease agreement. Of the $18,536 of outstanding letters of credit, the Company has collateralized $9,721 in cash, cash equivalents and investments and the remaining amounts are collateralized by the Revolver. Outstanding standby letters of credit at December 31, 2013 totaled $27,691.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	COMMITMENTS AND CONTINGENCIES
	(a) Legal
	The Company is subject to various claims and legal actions in the ordinary course of its business. Some of these matters relate to professional liability, tax, payroll, contract and employee-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment practices. During the first quarter of 2014, the Company completed the settlement of a wage and hour class action (and a related action) for an immaterial amount. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s clinicians and physicians. Depending upon the particular facts and circumstances, the Company may be subject to indemnification obligations under its contracts with certain clients relating to these matters.
	(b) Leases
	During the three months ended June 30, 2014, the Company entered into a third amendment (the “Third Amendment”) to its office lease (as amended to date, the “Lease”) with Kilroy Realty, L.P. for its corporate headquarters in San Diego. Among other things, the Third Amendment extended the term under the Lease nine additional years from its original termination date of August 1, 2018 through July 31, 2027 and also reduced the rental payment from January 1, 2015 through the original termination date in 2018. The Company recognizes rent expense on a straight-line basis over the lease term. Future minimum lease payments under the Third Amendment as of June 30, 2014 are as follows:
	Six months ending December 31, 2014	$	4,623
	Year ending December 31, 2015	6,500
	Year ending December 31, 2016	8,073
	Year ending December 31, 2017	8,355
	Year ending December 31, 2018	8,648
	Thereafter	87,892
	Total minimum lease payments	$	124,091

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Use of Estimates	'
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
Revenue Recognition	'
	Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians and physicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client.
Net Income per Common Share	'
	Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.
Segment Information	'
	The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
Fair Value Measurement	'
	Fair Value of Financial Instruments
	The carrying amount of notes payable approximates its fair value as the instrument’s interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity (significant other observable inputs - level 2). The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.
	Assets Measured on a Non-Recurring Basis
	The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment. If impaired, the carrying values of such assets would be written down to fair value using Level 3 inputs.
	Fair value represents the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which the Company would conduct a transaction, in addition to the assumptions that market participants would use when pricing the related assets or liabilities, including non-performance risk.
	A three-level hierarchy prioritizes the inputs to valuation techniques used to measure fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of the fair value hierarchy are as follows:
	Level 1—Quoted prices in active markets for identical assets or liabilities.
	Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	Assets Measured on a Recurring Basis
	The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments and the Company’s investments associated with its deferred compensation plan.

Net_Income_Per_Common_Share_Ta

Net Income Per Common Share (Tables)	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Computation of basic and diluted net income per common share	'
	The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2014 and 2013, respectively:
		Three Months Ended June 30,				Six Months Ended June 30,
		2014		2013		2014		2013
	Net income	$	7,193	$	8,399	$	14,823	$	15,962
	Net income per common share - basic	$	0.15	$	0.18	$	0.32	$	0.35
	Net income per common share - diluted	$	0.15	$	0.18	$	0.31	$	0.33
	Weighted average common shares outstanding - basic	46,479		46,039		46,416		45,927
	Plus dilutive effect of potential common shares	1,357		1,798		1,460		1,832
	Weighted average common shares outstanding - diluted	47,836		47,837		47,876		47,759

Segment_Information_Tables

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'
	The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:
		Three Months Ended June 30,				Six Months Ended June 30,
		2014		2013		2014		2013
	Revenue
	Nurse and allied healthcare staffing	$	165,894	$	170,138	$	329,344	$	346,903
	Locum tenens staffing	74,309		72,708		141,180		138,164
	Physician permanent placement services	10,710		11,097		21,270		20,996
		$	250,913	$	253,943	$	491,794	$	506,063
	Segment Operating Income
	Nurse and allied healthcare staffing	$	22,032	$	20,128	$	42,004	$	42,602
	Locum tenens staffing	7,818		4,908		14,691		9,800
	Physician permanent placement services	2,187		2,289		4,318		4,530
		32,037		27,325		61,013		56,932
	Unallocated corporate overhead	8,694		5,985		16,562		14,490
	Depreciation and amortization	4,010		3,240		7,830		6,530
	Share-based compensation	1,751		1,478		3,570		3,180
	Interest expense, net (including loss on debt extinguishment of $3,113 and $434 for both the three and six months ended June 30, 2014 and 2013, respectively) and other	4,629		3,130		6,475		5,989
	Income before income taxes	$	12,953	$	13,492	$	26,576	$	26,743

Fair_Value_Measurement_Tables

Fair Value Measurement (Tables)	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'
		Fair Value Measurements as of June 30, 2014
		Total		Quoted Prices in
				Active Markets
				for Identical
				Assets
				(Level 1)
	U.S. Treasury securities	$	9,350	$	9,350
	Money market funds	439		439
	Total financial assets measured at fair value	$	9,789	$	9,789
		Fair Value Measurements as of December 31, 2013
		Total		Quoted Prices in
				Active Markets
				for Identical
				Assets
				(Level 1)
	U.S. Treasury securities	$	17,817	$	17,817
	Money market funds	359		359
	Total financial assets measured at fair value	$	18,176	$	18,176

Notes_Payable_and_Related_Cred1

Notes Payable and Related Credit Agreement (Tables)	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Maturities of Long-term Debt	'
	Annual principal maturities of the outstanding Term Loan are as follows:
	Six months ending December 31, 2014	$	3,750
	Year ending December 31, 2015	7,500
	Year ending December 31, 2016	7,500
	Year ending December 31, 2017	7,500
	Year ending December 31, 2018	7,500
	Thereafter	$	114,375
		$	148,125

Commitments_and_Contingencies_

Commitments and Contingencies Leases (Tables)	6 Months Ended
	Jun. 30, 2014
Leases [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases	'
	Future minimum lease payments under the Third Amendment as of June 30, 2014 are as follows:
	Six months ending December 31, 2014	$	4,623
	Year ending December 31, 2015	6,500
	Year ending December 31, 2016	8,073
	Year ending December 31, 2017	8,355
	Year ending December 31, 2018	8,648
	Thereafter	87,892
	Total minimum lease payments	$	124,091

Business_Combination_and_Equit1

Business Combination and Equity Investment (Details) (USD $)	6 Months Ended			0 Months Ended	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Apr. 30, 2014	Mar. 31, 2014	Nov. 20, 2013	Jun. 30, 2014
	Pipeline Equity Investment [Member]	Pipeline Equity Investment [Member]	Pipeline Equity Investment [Member]	Shiftwise Acquisition	Shiftwise Acquisition
Business Combination, Description	'	'	'	'	'
Total purchase price of the acquisition	'	'	'	$39,500	'
Amount deposited into escrow	'	'	'	6,000	'
Escrow Deposit Disbursements	'	'	'	2,000	'
Allocation of Purchase Price	'	'	'	'	'
Fair Value of Assets Acquired	'	'	'	'	9,899
Liabilities Assumed	'	'	'	'	11,801
Deferred tax liability	'	'	'	'	2,933
Goodwill	'	'	'	'	21,612
Intangible assets	'	'	'	'	19,790
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Weighted average useful life of intangible assets	'	'	'	'	'8 years
Equity Method Investments and Joint Ventures [Abstract]	'	'	'	'	'
Equity method investment	'	1,000	2,000	'	'
Ownership percentage	12.00%	'	9.00%	'	'
Investment commitment	'	'	$3,000	'	'
Number of milestone commitments	2	'	'	'	'

Revenue_Recognition_Details

Revenue Recognition (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Revenue Recognition [Abstract]	'	'
Accounts Payable to Subcontractor	$24,936	$22,051

Net_Income_Per_Common_Share_De

Net Income Per Common Share (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Common stock excluded from calculation of EPS	385	334	373	321
Computation of basic and diluted net income per common share	'	'	'	'
Net income	$7,193	$8,399	$14,823	$15,962
Basic (in dollars per share)	$0.15	$0.18	$0.32	$0.35
Diluted (in dollars per share)	$0.15	$0.18	$0.31	$0.33
Weighted average common shares outstanding - basic	46,479	46,039	46,416	45,927
Plus dilutive effect of potential common shares	1,357	1,798	1,460	1,832
Weighted average common shares outstanding - diluted	47,836	47,837	47,876	47,759

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
			segment
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	$250,913	$253,943	$491,794	$506,063
Operating Income	17,582	16,622	33,051	32,732
Depreciation and amortization	4,010	3,240	7,830	6,530
Share-based compensation	1,751	1,478	3,570	3,180
Interest expense, net (including loss on debt extinguishment of $3,113 and $434 for both the three and six months ended June 30, 2014 and 2013, respectively) and other	4,629	3,130	6,475	5,989
Income before income taxes	12,953	13,492	26,576	26,743
Loss on debt extinguishment	3,113	434	3,113	434
Segment Information (Textual) [Abstract]	'	'	'	'
Reportable business segments	'	'	3	'
Operating segments [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	250,913	253,943	491,794	506,063
Operating Income	32,037	27,325	61,013	56,932
Operating segments [Member] | Nurse and allied healthcare staffing [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	165,894	170,138	329,344	346,903
Operating Income	22,032	20,128	42,004	42,602
Operating segments [Member] | Locum tenens staffing [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	74,309	72,708	141,180	138,164
Operating Income	7,818	4,908	14,691	9,800
Operating segments [Member] | Physician permanent placement services [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	10,710	11,097	21,270	20,996
Operating Income	2,187	2,289	4,318	4,530
Corporate, non-segment [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Unallocated corporate overhead	$8,694	$5,985	$16,562	$14,490

Fair_Value_Measurement_Financi

Fair Value Measurement - Financial Assets and Liabilities (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	$9,789	$18,176
US Treasury securities [Member]	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	9,350	17,817
Money Market Funds [Member]	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	439	359
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	9,789	18,176
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | US Treasury securities [Member]	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	9,350	17,817
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Money Market Funds [Member]	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	$439	$359

Notes_Payable_and_Related_Cred2

Notes Payable and Related Credit Agreement (Details) (USD $)

6 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Apr. 18, 2014

Jun. 30, 2014

Apr. 18, 2014

Jun. 30, 2014

Apr. 18, 2014

Apr. 18, 2014

Jun. 30, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Apr. 18, 2014

Jun. 30, 2014

Standby Letters of Credit [Member]

Standby Letters of Credit [Member]

Secured Debt [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Minimum [Member]

Maximum [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Credit Agreement [Member]

credit_facility

Letter of Credit [Member]

Letter of Credit [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Term Loan [Member]

Term Loan [Member]

Revolving Credit Facility, Swing Line Loan [Member]

Line of Credit [Member]

Line of Credit [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Revolving Credit Facility [Member]

Term Loan [Member]

Revolving Credit Facility [Member]

Term Loan [Member]

Revolving Credit Facility [Member]

Term Loan [Member]

Revolving Credit Facility [Member]

Term Loan [Member]

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of credit facilities

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility, available

'

'

'

'

$125,000,000

'

$40,000,000

'

$225,000,000

$150,000,000

'

$20,000,000

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt

'

'

'

'

'

'

'

'

'

'

148,125,000

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months

'

'

'

'

'

'

'

'

'

'

7,500,000

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Amount Outstanding

'

'

'

'

'

6,500,000

9,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letters of Credit Outstanding, Amount

'

18,536,000

27,691,000

9,721,000

'

8,815,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Remaining Borrowing Capacity

'

'

'

'

'

209,685,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unused fee

'

'

'

'

'

'

'

'

'

'

'

'

0.25%

0.35%

'

'

'

'

'

'

'

'

'

Letter of Credit Fee

'

'

'

'

'

'

'

'

'

'

'

'

1.50%

2.25%

'

'

'

'

'

'

'

'

'

Amortization of principal, rate

'

'

'

'

'

'

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Annual Principal Payment

'

'

'

'

'

'

'

'

'

7,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Weighted Average Interest Rate

'

'

'

'

'

'

'

1.75%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Basis spread

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.50%

1.50%

2.25%

2.25%

0.50%

0.50%

1.25%

1.25%

'

Deferred financing fees

3,488,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Initial maximum consolidated leverage ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4

Maximum consolidated leverage ratio beginning June 30, 2016

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.5

Minimum consolidated interest coverage ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.5

Write off of Deferred Debt Issuance Cost

$3,113,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes_Payable_and_Related_Cred3

Notes Payable and Related Credit Agreement Maturities (Details) (Line of Credit [Member], Term Loan [Member], USD $)	Jun. 30, 2014
In Thousands, unless otherwise specified
Line of Credit [Member] | Term Loan [Member]	'
Debt Instrument [Line Items]	'
Six months ending December 31, 2014	$3,750
Year ending December 31, 2015	7,500
Year ending December 31, 2016	7,500
Year ending December 31, 2017	7,500
Year ending December 31, 2018	7,500
Thereafter	114,375
Long-term Debt	$148,125

Commitments_and_Contingencies_1

Commitments and Contingencies Commitments and contingencies leases (Details) (USD $)	Jun. 30, 2014
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]	'
Six months ending December 31, 2014	$4,623
Year ending December 31, 2015	6,500
Year ending December 31, 2016	8,073
Year ending December 31, 2017	8,355
Year ending December 31, 2018	8,648
Thereafter	87,892
Total minimum lease payments	$124,091